Stay updated on Initial Myeloma: High-Dose vs Conventional RVD Clinical Trial
Sign up to get notified when there's something new on the Initial Myeloma: High-Dose vs Conventional RVD Clinical Trial page.

Latest updates to the Initial Myeloma: High-Dose vs Conventional RVD Clinical Trial page
- Check2 days agoChange DetectedThe page’s footer revision label has been updated from v3.5.0 to v3.5.3, reflecting a minor ClinicalTrials.gov site release without altering the displayed study record history.SummaryDifference0.1%

- Check17 days agoChange DetectedThe 2026-04-06 update adds References, Study Status, and Study Identification to the record history, and a 2019-04-18 deletion is noted in the changes.SummaryDifference0.6%

- Check38 days agoChange DetectedNew revision v3.5.0 added and v3.4.3 removed in the study record history. This update affects only the revision list and does not modify the underlying study data.SummaryDifference0.1%

- Check53 days agoChange DetectedNew revision entry v3.4.3 is added to the history, and the previous v3.4.2 entry is removed. This is a metadata update to the history log and does not modify study data.SummaryDifference0.1%

- Check74 days agoChange DetectedAdded a new revision entry v3.4.2 and removed the previous revision v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check82 days agoChange DetectedA new revision entry (v3.4.1) was added and the previous revision (v3.4.0) removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to Initial Myeloma: High-Dose vs Conventional RVD Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Initial Myeloma: High-Dose vs Conventional RVD Clinical Trial page.